127 related articles for article (PubMed ID: 8667604)
1. Thyroid dysfunction induced by interferon therapy for the treatment of hepatitis type C. A report of 4 cases.
Yamakawa Y; Sata M; Nakano H; Ide T; Noguchi S; Tokeshi S; Tanikawa K
Kurume Med J; 1995; 42(4):313-9. PubMed ID: 8667604
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
[TBL] [Abstract][Full Text] [Related]
4. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.
Dalgard O; Bjøro K; Hellum K; Myrvang B; Bjøro T; Haug E; Bell H
J Intern Med; 2002 May; 251(5):400-6. PubMed ID: 11982739
[TBL] [Abstract][Full Text] [Related]
5. Side effects of high-dose interferon therapy for chronic hepatitis C.
Okanoue T; Sakamoto S; Itoh Y; Minami M; Yasui K; Sakamoto M; Nishioji K; Katagishi T; Nakagawa Y; Tada H; Sawa Y; Mizuno M; Kagawa K; Kashima K
J Hepatol; 1996 Sep; 25(3):283-91. PubMed ID: 8895006
[TBL] [Abstract][Full Text] [Related]
6. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
8. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
9. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
[TBL] [Abstract][Full Text] [Related]
10. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid function abnormalities during interferon therapy].
Tsukada K; Nomura T; Higashi K; Takeuchi T
Nihon Rinsho; 1994 Jul; 52(7):1895-900. PubMed ID: 8078204
[TBL] [Abstract][Full Text] [Related]
13. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
14. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
Hass HG; Klein R; Nehls O; Kaiser S
J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
[TBL] [Abstract][Full Text] [Related]
15. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.
Sachithanandan S; Clarke G; Crowe J; Fielding JF
J Interferon Cytokine Res; 1997 Jul; 17(7):409-11. PubMed ID: 9243373
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.
Preziati D; La Rosa L; Covini G; Marcelli R; Rescalli S; Persani L; Del Ninno E; Meroni PL; Colombo M; Beck-Peccoz P
Eur J Endocrinol; 1995 May; 132(5):587-93. PubMed ID: 7749499
[TBL] [Abstract][Full Text] [Related]
17. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C.
Baudin E; Marcellin P; Pouteau M; Colas-Linhart N; Le Floch JP; Lemmonier C; Benhamou JP; Bok B
Clin Endocrinol (Oxf); 1993 Dec; 39(6):657-61. PubMed ID: 8287583
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
Tran A; Quaranta JF; Benzaken S; Thiers V; Chau HT; Hastier P; Regnier D; Dreyfus G; Pradier C; Sadoul JL
Hepatology; 1993 Aug; 18(2):253-7. PubMed ID: 7687977
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
